Implications of EPHB6, EFNB2, and EFNB3 expressions in human neuroblastoma
about
Negative and positive regulation of gene expression by mouse histone deacetylase 1Integrative genome-wide gene expression profiling of clear cell renal cell carcinoma in Czech Republic and in the United StatesEphB2 and EphB4 receptors forward signaling promotes SDF-1-induced endothelial cell chemotaxis and branching remodelingThe Transcription Regulator Krüppel-Like Factor 4 and Its Dual Roles of Oncogene in Glioblastoma and Tumor Suppressor in Neuroblastoma.Aberrant DNA methylation and epigenetic inactivation of Eph receptor tyrosine kinases and ephrin ligands in acute lymphoblastic leukemia.Ephrin-A2 reverse signaling negatively regulates neural progenitor proliferation and neurogenesis.Pregnancy complicated by obesity induces global transcript expression alterations in visceral and subcutaneous fat.Removing intensity effects and identifying significant genes for Affymetrix arrays in macrophage migration inhibitory factor-suppressed neuroblastoma cells.Inhibition of tumor growth and angiogenesis by soluble EphB4.Diverse roles for the Eph family of receptor tyrosine kinases in carcinogenesis.Identification of genetic risk associated with prostate cancer using ancestry informative markersQuantitative nuclear proteomics identifies that miR-137-mediated EZH2 reduction regulates resveratrol-induced apoptosis of neuroblastoma cellsEph receptors and ephrins as targets for cancer therapy.Clinical relevance of Ephs and ephrins in cancer: lessons from breast, colorectal, and lung cancer profiling.High expression of EphB6 protein in tongue squamous cell carcinoma is associated with a poor outcome.Coexpression of EphB4 and ephrinB2 in tumour advancement of ovarian cancers.Effects of overexpression of ephrin-B2 on tumour growth in human colorectal cancerMassive human co-expression network and its medical applicationsEphrin expression and function in cancer.Kidins220/ARMS is expressed in neuroblastoma tumors and stabilizes neurotrophic signaling in a human neuroblastoma cell line.Loss of the EPH receptor B6 contributes to colorectal cancer metastasisEPH-EPHRIN in human gastrointestinal cancersDancing with the dead: Eph receptors and their kinase-null partners.The Eph/Ephrin family in cancer metastasis: communication at the service of invasion.Reduced EphB6 protein in gastric carcinoma and associated lymph nodes suggests EphB6 as a gastric tumor and metastasis inhibitor.Aurora kinase A is a possible target of OSU‑03012 to destabilize MYC family proteins.Hsp90 inhibition increases p53 expression and destabilizes MYCN and MYC in neuroblastoma.Biological effects of induced MYCN hyper-expression in MYCN-amplified neuroblastomas.Destabilization of MYC/MYCN by the mitochondrial inhibitors, metaiodobenzylguanidine, metformin and phenformin.S(+)-ibuprofen destabilizes MYC/MYCN and AKT, increases p53 expression, and induces unfolded protein response and favorable phenotype in neuroblastoma cell lines.Biological significance of EPHA2 expression in neuroblastoma.Krüppel-like factor 4 (KLF4) suppresses neuroblastoma cell growth and determines non-tumorigenic lineage differentiation.MicroRNA-10a is involved in the metastatic process by regulating Eph tyrosine kinase receptor A4-mediated epithelial-mesenchymal transition and adhesion in hepatoma cells.EphrinA1 repulsive response is regulated by an EphA2 tyrosine phosphatase.Expression of EphB6 in ovarian serous carcinoma is associated with grade, TNM stage and survival.Reduced expression of erythropoietin-producing hepatocyte B6 receptor tyrosine kinase in prostate cancerExpression profile of Eph receptors and ephrin ligands in human skin and downregulation of EphA1 in nonmelanoma skin cancer.Expression of EphrinB2 and EphB4 in glioma tissues correlated to the progression of glioma and the prognosis of glioblastoma patients.Complementary and layered expression of Ephs and ephrins in developing mouse inner ear.Clinical Significance of EphB4 and EphB6 Expression in Human Malignant and Benign Thyroid Lesions.
P2860
Q24672508-BF4F074C-C2FD-4420-9791-A484B03CC126Q28487676-2DE65D0A-6845-4E25-8911-F6999814A260Q30479634-630022AD-1D37-43B7-9B95-5E295BC06776Q33652886-E3C506C2-CA59-4675-9E54-D9F12ABA4CAAQ33754623-112169F5-CD46-4129-AA45-51DA01602A92Q33848991-4D2C77C0-D56D-4FFC-8A7F-0E8344075946Q33954314-C04CBB9E-B3E6-48BD-B9E7-F746ADCA2B7AQ34202118-114C1B1E-604B-446B-9B32-FEBE71244BFBQ34770033-C9C6C7A5-E7AA-4CBD-8A9E-00274211CA0AQ34872708-CD6D4B4D-EAE5-4533-A016-3F3FFC6B0BC5Q34918166-79077278-8B32-4B72-A24F-0E3CEC39A7A5Q35148549-BEEE4383-E2EA-4F8A-993B-FCFB9E2C1736Q35370195-62ABA443-B970-4D7C-BC6A-D06C87DA5C53Q35783568-55390C0A-30FB-45B7-B11C-2AC3097DB8DDQ36261833-6D6AF097-362C-4089-AE1F-5E4666B50641Q36484515-E1279B20-9A85-44AC-A460-5A6FCE248BCAQ36694994-A086363F-96FD-4BDE-9F14-12C24E58C306Q37013849-206951F8-6B68-4C3E-B254-3EED2E0D71C9Q37658786-1A09B824-15C1-4018-9DEA-94F4D566FE91Q37670800-E334A59A-7567-4CAD-88A6-F0CF45CB101EQ37681807-ECBECE46-234D-46D4-907E-B5032F45A644Q37824603-9094DACD-EF73-46F3-805D-905525BECCD4Q37860149-B68C6D4F-19EC-4A37-840E-A4B283D36240Q38006838-BAF6BF0D-E480-44EE-A84D-48E77A1125E6Q38814701-5ACF3C7F-0CA3-446C-A7D4-EF6ED2450709Q38975838-38C42C44-3D81-4BE9-ADF6-75C2BAB47537Q39016943-459716FA-64C3-41E5-BBE5-BA6B22738F84Q39022300-F2837EA4-7713-4822-9EAB-EB2FB1659D18Q39067047-642D29EA-2256-4A98-B5E6-4A2C1FB9D669Q39068591-46EF883F-5418-41FC-8839-675C6B168332Q39227009-4EC0D825-3CA8-42C0-8402-84D74A1D98E1Q39263949-3DF1DE9F-595A-4355-8D7C-440C92FA4BD1Q39274635-383892CB-7545-48B9-A651-07935C91DA84Q40392006-91E1679E-EDFE-4415-BEB4-A41F4763B9F0Q41219933-BA4B7FC9-C39C-494C-BBF1-A97B68FF1801Q41837480-3403F73C-AF41-446C-8330-B5D78DA2DE2DQ42498631-6D261FCD-E602-4DC9-AA7E-784FB386F7F6Q45548546-2336A921-ED3B-4A89-AF10-4927EE525EF3Q50487302-F00DF52A-0662-4DC6-8392-526F5763A93AQ53403455-0B5D54A9-25DF-43A7-BF83-3FB2789C1BF4
P2860
Implications of EPHB6, EFNB2, and EFNB3 expressions in human neuroblastoma
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Implications of EPHB6, EFNB2, and EFNB3 expressions in human neuroblastoma
@ast
Implications of EPHB6, EFNB2, and EFNB3 expressions in human neuroblastoma
@en
Implications of EPHB6, EFNB2, and EFNB3 expressions in human neuroblastoma
@nl
type
label
Implications of EPHB6, EFNB2, and EFNB3 expressions in human neuroblastoma
@ast
Implications of EPHB6, EFNB2, and EFNB3 expressions in human neuroblastoma
@en
Implications of EPHB6, EFNB2, and EFNB3 expressions in human neuroblastoma
@nl
prefLabel
Implications of EPHB6, EFNB2, and EFNB3 expressions in human neuroblastoma
@ast
Implications of EPHB6, EFNB2, and EFNB3 expressions in human neuroblastoma
@en
Implications of EPHB6, EFNB2, and EFNB3 expressions in human neuroblastoma
@nl
P2093
P2860
P356
P1476
Implications of EPHB6, EFNB2, and EFNB3 expressions in human neuroblastoma
@en
P2093
G M Brodeur
M E Robinson
N K Cheung
P2860
P304
P356
10.1073/PNAS.190123297
P407
P577
2000-09-26T00:00:00Z